DJIA 17,804.80 26.65 0.15%
NASDAQ 4,765.38 16.98 0.36%
S&P 500 2,070.65 9.42 0.46%
market minute promo

Sarepta Therapeutics (NASDAQ: SRPT)

13.21 -0.59 (-4.28%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

SRPT $13.21 -4.28%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $13.76
Previous Close $13.80
Daily Range $13.19 - $13.76
52-Week Range $12.58 - $40.00
Market Cap $545.7M
P/E Ratio -5.63
Dividend (Yield) $0.00 (0.0%)
Volume 2,867,261
Average Daily Volume 1,278,712
Current FY EPS -$3.19





Sarepta Therapeutics (SRPT) Description

A biopharmaceutical company developing therapeutic products principally based on third-generation NEUGENE antisense technology. Website:

News & Commentary

Twitter's Favorite Biotech and Pharma Stocks

Consensus? We don't need no stinking consensus!

Pfizer's Duchenne Muscular Dystrophy Drug in Phase II - Analyst Blog

Pfizer's Duchenne Muscular Dystrophy Drug in Phase II - Analyst Blog

2014 Healthcare Stock Report Card: Sobek Tracks His Hits and Misses

Does George Soros Think Biotech's Bull Run Is Finally Coming to an End?

The Soros Fund Managment sold off a number of biotechs in the third quarter. Do the actions of this closely watched fund signal that the industry's bull run is finally winding down?

Stocks Hitting 52-Week Lows

With Mid-2015 NDA Submission, Sarepta Can Rise

The 3 Most Memorable Moments in Healthcare This Year

Three Motley Fool analysts tell investors what they believe are the year's most memorable events in the healthcare sector.

Biotech Stock Mailbag: Aethlon Medical, Oxigene, Sarepta

Rolling with Biotech’s Regulatory Punches: Chen Lin

Health Care Sector Update for 11/26/2014: SRPT,RNA,BMRN,BDX,MRGE

See More SRPT News...

SRPT's Top Competitors

SRPT $13.21 (-4.28%)
Current stock: SRPT
AMGN $170.17 (1.00%)
Current stock: AMGN
GILD $108.45 (2.76%)
Current stock: GILD
BIIB $360.67 (1.97%)
Current stock: BIIB